No Data
No Data
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Leerink Partners Maintains Pliant Therapeutics(PLRX.US) With Buy Rating, Maintains Target Price $33
Positive Developments in Pliant Therapeutics' IPF Research Bolster Buy Rating
Pliant Therapeutics Reports Increased Losses and Strategic Focus
Express News | Pliant Therapeutics Plans To Present Data From Bexotegrast Program At Liver Meeting 2024